416 related articles for article (PubMed ID: 8794769)
1. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
Liu R; Sharom FJ
Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.
Liu R; Sharom FJ
Biochemistry; 1997 Mar; 36(10):2836-43. PubMed ID: 9062112
[TBL] [Abstract][Full Text] [Related]
3. Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study.
Liu R; Sharom FJ
Biochemistry; 1998 May; 37(18):6503-12. PubMed ID: 9572868
[TBL] [Abstract][Full Text] [Related]
4. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
[TBL] [Abstract][Full Text] [Related]
5. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.
Qu Q; Russell PL; Sharom FJ
Biochemistry; 2003 Feb; 42(4):1170-7. PubMed ID: 12549939
[TBL] [Abstract][Full Text] [Related]
6. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
Ramachandra M; Ambudkar SV; Chen D; Hrycyna CA; Dey S; Gottesman MM; Pastan I
Biochemistry; 1998 Apr; 37(14):5010-9. PubMed ID: 9538020
[TBL] [Abstract][Full Text] [Related]
7. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence of native single-Trp mutants in the lactose permease from Escherichia coli: structural properties and evidence for a substrate-induced conformational change.
Weitzman C; Consler TG; Kaback HR
Protein Sci; 1995 Nov; 4(11):2310-8. PubMed ID: 8563627
[TBL] [Abstract][Full Text] [Related]
9. The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2004 Sep; 43(38):12081-9. PubMed ID: 15379547
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide binding to the multidrug resistance P-glycoprotein as studied by ESR spectroscopy.
Delannoy S; Urbatsch IL; Tombline G; Senior AE; Vogel PD
Biochemistry; 2005 Oct; 44(42):14010-9. PubMed ID: 16229490
[TBL] [Abstract][Full Text] [Related]
11. FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.
Qu Q; Sharom FJ
Biochemistry; 2001 Feb; 40(5):1413-22. PubMed ID: 11170469
[TBL] [Abstract][Full Text] [Related]
12. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
Rao US
Biochemistry; 1998 Oct; 37(42):14981-8. PubMed ID: 9778376
[TBL] [Abstract][Full Text] [Related]
13. The catalytic cycle of P-glycoprotein.
Senior AE; al-Shawi MK; Urbatsch IL
FEBS Lett; 1995 Dec; 377(3):285-9. PubMed ID: 8549739
[TBL] [Abstract][Full Text] [Related]
14. Binding of steroid modulators to recombinant cytosolic domain from mouse P-glycoprotein in close proximity to the ATP site.
Dayan G; Jault JM; Baubichon-Cortay H; Baggetto LG; Renoir JM; Baulieu EE; Gros P; Di Pietro A
Biochemistry; 1997 Dec; 36(49):15208-15. PubMed ID: 9398248
[TBL] [Abstract][Full Text] [Related]
15. The relationship between MRP1 activities and its NBD conformational changes.
Huang Z; Huang Y
Sci China C Life Sci; 2004 Oct; 47(5):425-33. PubMed ID: 15623154
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of P-glycoprotein ATPase by analogues of tetramethylrosamine: coupling of drug binding at the "R" site to the ATP hydrolysis transition state.
Tombline G; Donnelly DJ; Holt JJ; You Y; Ye M; Gannon MK; Nygren CL; Detty MR
Biochemistry; 2006 Jul; 45(26):8034-47. PubMed ID: 16800628
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of P-glycoprotein tryptophan residues to benzodiazepines and ATP interaction.
Lima SA; Cordeiro-da-Silva A; de Castro B; Gameiro P
Biophys Chem; 2007 Jan; 125(1):143-50. PubMed ID: 16919386
[TBL] [Abstract][Full Text] [Related]
18. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
[TBL] [Abstract][Full Text] [Related]
19. P glycoprotein and the mechanism of multidrug resistance.
Váradi A; Szakács G; Bakos E; Sarkadi B
Novartis Found Symp; 2002; 243():54-65; discussion 65-8, 180-5. PubMed ID: 11990782
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the "occluded nucleotide conformation" of P-glycoprotein in the catalytic pathway.
Tombline G; Muharemagić A; White LB; Senior AE
Biochemistry; 2005 Sep; 44(38):12879-86. PubMed ID: 16171403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
